Market By Immunotherapy, Diagnostics, Treatments And Geography | Forecast 2019-2027
Allergy can be defined as a damaging immune response by the body to a substance, such as a particular food, fur, dust or pollen, to which it has become hypersensitive. Patients suffering from any allergic diseases experience a low quality of life.
According to Triton, the global allergy diagnostic and treatment market is expected to display a positive market trend over the forecast period of 2019-2027, exhibiting a CAGR of 5.27%. The market was assessed to be worth $30055 million in the year 2018 and is predicted to generate a revenue of approximately $47706 million by the year 2027.
We provide additional customization based on your specific requirements. Request For Customization
Diagnosis of allergies mainly consists of allergy skin testing, the most sensitive method of testing that provides almost instant results. One of the most prevalent tests used for allergy diagnosis is the prick test, where the skin is pricked coupled with the extraction of a specific allergen and then spotting the reaction of the skin. Another is the serum-specific IgE antibody testing, which involves blood tests that similarly determines the allergen’s information.
The best way to avoid allergy is not to offend the allergens. This can be achieved if the allergen is a type of a particular food, that can be eliminated from the diet easily, ex: peanut, milk, etc. However, this method is not feasible when the ambient environment contains the allergens, like the ragweed pollen. Numerous OTC or prescription medications can relieve the general symptoms of allergy. Some of these medications are antihistamines, nasal steroids and immunotherapy (allergy shots).
Antihistamines are substances used as medication drugs that can fight the direct effects of histamine, which is the immune response particle that makes the eyes watery, the nose itchy and trigger one to sneeze during allergic reactions to flush out the foreign bodies from the living system.
Nasal steroids are the anti-inflammatory sprays which reduce mucus formation, inflammation and swelling. They are prescribed both independently and are sometimes combined with specific antihistamines. They have less number of side-effects.
Immunotherapy (allergy shots) may provide relief to patients who don't find relief through the antihistamines or nasal steroids. These shots are used for altering the body's immune response to various allergic particles or allergens, to prevent the allergic reactions.
Within the report on the allergy diagnostic and treatment market, Triton has discussed the supply chain outlook and the key insights regarding the industry. Also, the patent outlook, key buying outlook and Porter’s five force outlook have been studied for the allergy diagnostic and treatment industry.
Market drivers like increasing air pollution, rise in tobacco consumption and increasing prevalence of allergic diseases are responsible for developing the market. However, restraints like probable side effects of drugs, stringent regulations, high capital requirements for R&D and tools as well as the dearth of cognizance among people about the allergy are the top factors obstructing the industry’s growth over the forecast period.
To get detailed insights on segments, Request Free Sample Report
Key opportunities like the upsurge in the awareness about allergic diseases and high growth opportunities in developing economies can be leveraged by the industry to achieve the projected growth. On the contrary, the expiry of major drugs in the offing, accessibility of generic drugs in the market, availability of alternative treatments and increasing healthcare expenditure are the major factors that are expected to challenge the market growth over the coming years.
The major geographies covered in the allergy diagnostic and treatment market are:
• North America: United States and Canada
• Europe: United Kingdom, Germany, France, Italy, Spain, Russia and Rest of Europe
• Asia-Pacific: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and Rest of Asia-Pacific
• Latin America: Brazil, Mexico and Rest of Latin America
• The Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa and Rest of the Middle East and Africa
The allergy diagnostic and treatment market is segmented into:
• By Immunotherapy:
O Sublingual Liquid Solutions
O Subcutaneous Administration
O Sublingual Tablets
• By Diagnostics:
O Antibody
O Skin Testing
• By Treatments:
O By Availability
• Prescription
• Over the Counter
O By Administration
• Topical
• Spray
• Oral
• Ocular
O By Product
• Antihistamines
• Mast Cell Stabilizers
• Corticosteroids
• Leukotrienes
• Sympathomimetics, Decongestants and Combinations
The key players engaged in the allergy diagnostic and treatment market are GlaxoSmithKline PLC, Beckmann Coulter, Mylan N.V., Merck, Hitachi Chemical Diagnostics, Inc., Pfizer, Johnson & Johnson, Sanofi, F. Hoffmann-La Roche, Ltd. and Allergan PLC.
The strategic analysis for each of these companies in the allergy diagnostic and treatment market has been covered in detail in the report. The company market share enables to study the information about the key market players in this industry and their position in the market.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ALLERGY
DIAGNOSTIC AND TREATMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES OUTLOOK
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF RIVALRY
2.3. VENDOR
SCORECARD
2.4. PATENT
OUTLOOK
2.5. KEY
BUYING OUTLOOK
2.6. KEY
INSIGHTS
2.7. SUPPLY
CHAIN OUTLOOK
2.8. MARKET
DRIVERS
2.8.1. INCREASING
AIR POLLUTION
2.8.2. RISE
IN TOBACCO CONSUMPTION
2.8.3. INCREASE
IN THE PREVALENCE OF ALLERGIC DISEASES
2.9. MARKET
RESTRAINTS
2.9.1. PROBABLE
SIDE-EFFECTS OF DRUGS IS THE RESTRAINING FACTOR
2.9.2. STRINGENT
REGULATIONS
2.9.3. CAPITAL
REQUIREMENTS IS HIGH FOR THE R&D OF DIAGNOSTIC AND TREATMENTS TOOLS
2.9.4. DEARTH
OF COGNIZANCE AMONG THE PEOPLE ABOUT ALLERGIES
2.10.
MARKET OPPORTUNITIES
2.10.1.
UPSURGE IN AWARENESS ABOUT
ALLERGIC DISEASES
2.10.2.
HIGH GROWTH OPPORTUNITIES IN
DEVELOPING ECONOMIES
2.11.
MARKET CHALLENGES
2.11.1.
EXPIRY OF MAJOR DRUGS IN THE
OFFING
2.11.2.
ACCESSIBILITY OF GENERIC DRUGS
IN THE MARKET
2.11.3.
AVAILABILITY OF ALTERNATE
TREATMENTS
2.11.4.
SWELLING HEALTHCARE
EXPENDITURE
3. ALLERGY
DIAGNOSTIC AND TREATMENT MARKET OUTLOOK - BY IMMUNOTHERAPY, DIAGNOSTIC AND
TREATMENTS
3.1. IMMUNOTHERAPY
3.1.1. SUBLINGUAL
LIQUID SOLUTIONS
3.1.2. SUBCUTANEOUS
ADMINISTRATION
3.1.3. SUBLINGUAL
TABLETS
3.2. DIAGNOSTICS
3.2.1. ANTIBODY
3.2.2. SKIN
TESTING
3.3. TREATMENTS
3.3.1. TREATMENT
MARKET BY AVAILABILITY
3.3.1.1. PRESCRIPTION
3.3.1.2. OVER
THE COUNTER
3.3.2. TREATMENT
MARKET BY ADMINISTRATION
3.3.2.1. TOPICAL
3.3.2.2. SPRAY
3.3.2.3. ORAL
3.3.2.4. OCULAR
3.3.3. TREATMENT
MARKET BY PRODUCTS
3.3.3.1. ANTIHISTAMINES
3.3.3.2. MAST
CELL STABILIZERS
3.3.3.3. CORTICOSTEROIDS
3.3.3.4. LEUKOTRIENES
3.3.3.5. SYMPATHOMIMETICS,
DECONGESTANTS AND COMBINATIONS
4. ALLERGY
DIAGNOSTIC AND TREATMENT MARKET - REGIONAL OUTLOOK
4.1. NORTH
AMERICA
4.1.1. COUNTRY
ANALYSIS
4.1.1.1. THE
UNITED STATES
4.1.1.2. CANADA
4.2. EUROPE
4.2.1. COUNTRY
ANALYSIS
4.2.1.1. GERMANY
4.2.1.2. FRANCE
4.2.1.3. THE
UK
4.2.1.4. RUSSIA
4.2.1.5. ITALY
4.2.1.6. SPAIN
4.2.1.7. REST
OF EUROPE
4.3. ASIA-PACIFIC
4.3.1. COUNTRY
ANALYSIS
4.3.1.1. INDIA
4.3.1.2. CHINA
4.3.1.3. JAPAN
4.3.1.4. AUSTRALIA
& NEW ZEALAND
4.3.1.5. SOUTH
KOREA
4.3.1.6. ASEAN
COUNTRIES
4.3.1.7. REST
OF APAC
4.4. MIDDLE
EAST AND AFRICA
4.4.1. COUNTRY
ANALYSIS
4.4.1.1. UNITED
ARAB EMIRATES
4.4.1.2. TURKEY
4.4.1.3. SAUDI
ARABIA
4.4.1.4. SOUTH
AFRICA
4.4.1.5. REST
OF MIDDLE EAST AND AFRICA
4.5. LATIN
AMERICA
4.5.1. COUNTRY
ANALYSIS
4.5.1.1. BRAZIL
4.5.1.2. MEXICO
4.5.1.3. REST
OF LATIN AMERICA
5. COMPETITIVE
LANDSCAPE
5.1. GLAXOSMITHKLINE,
PLC
5.2. MYLAN
N.V.
5.3. HITACHI
CHEMICAL DIAGNOSTICS, INC.
5.4. JOHNSON
& JOHNSON
5.5. F.
HOFFMANN-LA ROCHE, LTD.
5.6. BECKMAN
COULTER
5.7. MERCK
5.8. PFIZER
5.9. SANOFI
5.10.
ALLERGAN PLC
5.11.
THERMO FISHER DIAGNOSTICS
6. RESEARCH
SCOPE AND METHODOLOGY
6.1. RESEARCH
SCOPE
6.2. SOURCES
OF DATA
6.3. RESEARCH
METHODOLOGY
TABLE 1 GLOBAL ALLERGY DIAGNOSTIC
AND TREATMENT MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)
TABLE 2 GLOBAL ALLERGY DIAGNOSTIC
AND TREATMENT MARKET BY TREATMENTS, DIAGNOSTICS AND IMMUNOTHERAPY 2019-2027 ($
MILLION)
TABLE 3 GLOBAL ALLERGY DIAGNOSTIC
AND TREATMENT MARKET IN IMMUNOTHERAPY 2019-2027 ($ MILLION)
TABLE 4 GLOBAL ALLERGY DIAGNOSTIC
AND TREATMENT MARKET IN DIAGNOSTICS 2019-2027 ($ MILLION)
TABLE 5 GLOBAL ALLERGY DIAGNOSTIC
AND TREATMENT MARKET IN TREATMENTS, BY AVAILABILITY, 2019-2027 ($ MILLION)
TABLE 6 GLOBAL ALLERGY DIAGNOSTIC
AND TREATMENT MARKET IN TREATMENTS, BY ADMINISTRATION, 2019-2027 ($ MILLION)
TABLE 7 GLOBAL ALLERGY DIAGNOSTIC
AND TREATMENT MARKET IN TREATMENTS, BY PRODUCTS, 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA ALLERGY DIAGNOSTIC
AND TREATMENT MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
TABLE 9 EUROPE ALLERGY DIAGNOSTIC
AND TREATMENT MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
TABLE 10 ASIA-PACIFIC ALLERGY DIAGNOSTIC AND
TREATMENT MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
TABLE 11 MIDDLE EAST AND AFRICA ALLERGY DIAGNOSTIC
AND TREATMENT MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
TABLE 12 LATIN AMERICA ALLERGY DIAGNOSTIC AND
TREATMENT MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
FIGURE 1 GLOBAL ALLERGY DIAGNOSTIC AND TREATMENT
MARKET 2019-2027 ($ MILLION)
FIGURE 2 KEY BUYING CRITERIA OF ALLERGY DIAGNOSTIC
AND TREATMENT MARKET
FIGURE 3 GLOBAL TREATMENTS MARKET IN SUBLINGUAL
LIQUID SOLUTIONS 2019-2027 ($ MILLION)
FIGURE 4 GLOBAL TREATMENTS MARKET IN SUBCUTANEOUS
ADMINISTRATION 2019-2027 ($ MILLION)
FIGURE 5 GLOBAL TREATMENTS MARKET IN SUBLINGUAL
TABLETS 2019-2027 ($ MILLION)
FIGURE 6 GLOBAL TREATMENTS MARKET IN ANTIBODY
2019-2027 ($ MILLION)
FIGURE 7 GLOBAL DIAGNOSTICS MARKET IN SKIN TESTING
2019-2027 ($ MILLION)
FIGURE 8 GLOBAL TREATMENTS MARKET IN PRESCRIPTION
2019-2027 ($ MILLION)
FIGURE 9 GLOBAL TREATMENTS MARKET IN OVER THE
COUNTER 2019-2027 ($ MILLION)
FIGURE 10 GLOBAL TREATMENTS MARKET IN TOPICAL 2019-2027
($ MILLION)
FIGURE 11 GLOBAL TREATMENTS MARKET IN SPRAY 2019-2027
($ MILLION)
FIGURE 12 GLOBAL TREATMENTS MARKET IN ORAL 2019-2027 ($
MILLION)
FIGURE 13 GLOBAL TREATMENTS MARKET IN OCULAR 2019-2027
($ MILLION)
FIGURE 14 GLOBAL TREATMENTS MARKET IN ANTIHISTAMINES
2019-2027 ($ MILLION)
FIGURE 15 GLOBAL TREATMENTS MARKET IN MAST CELL
STABILIZERS 2019-2027 ($ MILLION)
FIGURE 16 GLOBAL TREATMENTS MARKET IN CORTICOSTEROIDS
2019-2027 ($ MILLION)
FIGURE 17 GLOBAL TREATMENTS MARKET IN LEUKOTRIENES
2019-2027 ($ MILLION)
FIGURE 18 GLOBAL TREATMENTS MARKET IN SYMPATHOMIMETICS,
DECONGESTANTS AND COMBINATIONS 2019-2027 ($ MILLION)
FIGURE 19 THE UNITED STATES ALLERGY DIAGNOSTIC AND
TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 20 CANADA ALLERGY DIAGNOSTIC AND TREATMENT
MARKET 2019-2027 ($ MILLION)
FIGURE 21 PERCENTAGE OF PEOPLE SUFFERING FROM SEVERE
FOOD ALLERGY IN CANADA 2017
FIGURE 22 GERMANY ALLERGY DIAGNOSTIC AND TREATMENT
MARKET 2019-2027 ($ MILLION)
FIGURE 23 FRANCE ALLERGY DIAGNOSTIC AND TREATMENT
MARKET 2019-2027 ($ MILLION)
FIGURE 24 THE UNITED KINGDOM ALLERGY DIAGNOSTIC AND
TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 25 RUSSIA ALLERGY DIAGNOSTIC AND TREATMENT
MARKET 2019-2027 ($ MILLION)
FIGURE 26 ITALY ALLERGY DIAGNOSTIC AND TREATMENT MARKET
2019-2027 ($ MILLION)
FIGURE 27 SPAIN ALLERGY DIAGNOSTIC AND TREATMENT MARKET
2019-2027 ($ MILLION)
FIGURE 28 REST OF EUROPE ALLERGY DIAGNOSTIC AND
TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 29 INDIA ALLERGY DIAGNOSTIC AND TREATMENT MARKET
2019-2027 ($ MILLION)
FIGURE 30 CHINA ALLERGY DIAGNOSTIC AND TREATMENT MARKET
2019-2027 ($ MILLION)
FIGURE 31 JAPAN ALLERGY DIAGNOSTIC AND TREATMENT MARKET
2019-2027 ($ MILLION)
FIGURE 32 AUSTRALIA & NEW ZEALAND ALLERGY DIAGNOSTIC
AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 33 SOUTH KOREA ALLERGY DIAGNOSTIC AND TREATMENT
MARKET 2019-2027 ($ MILLION)
FIGURE 34 ASEAN COUNTRIES ALLERGY DIAGNOSTIC AND
TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 35 REST OF APAC ALLERGY DIAGNOSTIC AND TREATMENT
MARKET 2019-2027 ($ MILLION)
FIGURE 36 THE UAE ALLERGY DIAGNOSTIC AND TREATMENT
MARKET 2019-2027 ($ MILLION)
FIGURE 37 TURKEY ALLERGY DIAGNOSTIC AND TREATMENT
MARKET 2019-2027 ($ MILLION)
FIGURE 38 SAUDI ARABIA ALLERGY DIAGNOSTIC AND TREATMENT
MARKET 2019-2027 ($ MILLION)
FIGURE 39 SOUTH AFRICA ALLERGY DIAGNOSTIC AND TREATMENT
MARKET 2019-2027 ($ MILLION)
FIGURE 40 REST OF MIDDLE EAST AND AFRICA ALLERGY DIAGNOSTIC
AND TREATMENT MARKET 2019-2027 ($ MILLION)
FIGURE 41 BRAZIL ALLERGY DIAGNOSTIC AND TREATMENT
MARKET 2019-2027 ($ MILLION)
FIGURE 42 MEXICO ALLERGY DIAGNOSTIC AND TREATMENT
MARKET 2019-2027 ($ MILLION)
FIGURE 43 REST OF LATIN AMERICA ALLERGY DIAGNOSTIC AND
TREATMENT MARKET 2019-2027 ($ MILLION)